I-Cyclobenzaprine ye-Fibromyalgia Pain

I-Relaxer ye-Muscle + I-Antidepressant

Sibanzi

I-Cyclobenzaprine i-relaxation ye-muscle efumaneka kwifom ejwayelekile kunye nangaphansi kwegama le-brand Flexeril kunye ne-Amrix. Kucingwa unyango lwe-line ye- fibromyalgia.

Esi sidakamizwa sinemiphumo emihle efana neye-tricyclic anti-depressants, eyaziwayo ngokuqhelekileyo kule miqathango.

I-Cyclobenzaprine ayikho i-FDA-evunyelwe i-fibromyalgia, kodwa idlalwa rhoqo kwi-ileyile.

I-Cyclobenzaprine ivuselela izihlunu zakho ngokusebenza kwinkqubo yakho ye-nervous central . Oogqirha babesoloko beyichaza ngokulimala kwemisipha kunye nentlungu engapheliyo.

Kuphononongo, eli chiza lifunyenwe ukuphucula umgangatho wokulala kwakhona.

Fibromyalgia Studies

I-Cyclobenzaprine iye yafundiswa njengonyango lwe-fibromyalgia ukususela ngo-1980, kunye neziphumo ezidibeneyo.

Ukuhlaziywa kwezidakamizwa ka-2011 (Smith) ezisetyenziselwa i-fibromyalgia kufumaneka ukuba enye yezilingo ezintathu zibandakanyiwe zibonisa ukuba i-cyclobenzaprine inciphise intlungu ye-fibromyalgia. Uvavanyo oluphumelelayo lubonise ukuphuculwa kokulala, kunye nokuphuculwa ngokubanzi. Nangona kunjalo, abaphandi abafumani nantlukwano ebalulekileyo ekukhuni, ukukhathala, amanqaku eethenda , ukuqina kwemisipha, okanye umthwalo weentlungu.

Ukuphononongwa kufumaniswe ukuba iziphumo ezivela kwiilingo ezincinci azizange zibonakalise, mhlawumbi kuba zibandakanya abantu abambalwa.

Uhlalutyo lwangaphambili (I-Tofferi) lweencwadi zonyango lubonisa ukuba izigulane ze-fibromyalgia ezithatha i-cyclobenzaprine zaziphindwe kathathu ukuba zibheke ukulala okungcono, iimpawu ezimbalwa kunye nokuphucula okubanzi kunabantu abakwiqela lokulawula.

Olunye uphando oludala lubhekiselele ekuphuculweni kwithuba elifutshane, kodwa akukho phuculo olude olude olude.

Ngo-2011, isifundo esincinci esagxile kwi-physiology yokulala (iMoldofsky) yagqiba ukuba i-dose ephantsi kakhulu i-cyclobenzaprine yaphucula umgangatho wobuthongo kubantu abane-fibromyalgia. Abaphandi bathi baphinde babona ukuphucula intlungu, ukunyamezela nokudandatheka .

Isistim

Umlinganiselo omdala we-cyclobenzaprine uphakathi ko-5 no-10 mg, uthathwa kathathu ngosuku. Ifom ekhutshwe ngokukhawuleza, ngokuqhelekileyo ithathwa ngamayeza angama-15 ukuya ku-30 ​​mg ngosuku, iyafumaneka.

Kwilingo le-fibromyalgia kwi-physiology yokulala, abathathi-nxaxheba banikezwa ngokunyuka kwamazinga oku-1 ukuya ku-4 mg, bathathwa kuphela ngexesha lokulala.

Amanqanaba amancinci axhomekeke kwimiphumo emibini yecala.

Imiphumela

Ezinye iziphumo ezisecaleni ze-cyclobenzaprine zinzulu ngokwaneleyo ukuba kufuneka uzixelele ugqirha wakho ngokukhawuleza. Ziquka:

Iziphumo ezincinci ezibi ziquka:

ILizwi

Ukuba unomdla wokuthatha i-cyclobenzaprine, xela ugqirha wakho malunga nalo. Unokukunceda ukuba wenze isigqibo sokuba ngaba le nyeza inokukunceda kuwe kwaye ukhusele ukuhamba kunye nezinye iyeza.

Imithombo:

Cantini F, et al. Minerva medica. 1994 Mar; 85 (3): 97-100. Inqaku kuphela, inqaku kwisiNtaliyane. I-Fluoxetin ihlangene ne-cyclobenzaprine kwonyango lwe-fibromyalgia.

Carette S, et al. Arthritis kunye ne-rheumatism. 1994 Jan; 37 (1): 32-40. Ukuthelekisa i-amitriptyline, i-cyclobenzaprine, kunye ne-placebo kunyango lwe-fibromyalgia. Uvavanyo lweklinikhi olungenangqondo, oluphindwe kabini.

Moldofsky H, et al. Journal of rheumatology. NgoDisemba ka-2011; 38 (12): 2653-63. Imiphumo yexesha lokulala kakhulu i-dock cyclobenzaprine kwiimpawu kunye nokulala kwezilwanyana kwizigulane ezine-fibromyalgia syndrome: isifundo esilawulwa yimibala engaphantsi kwimibala engabonakaliyo.

Santandrea S, et al. Umbhalo wophando lwezoqoqosho lwamazwe ngamazwe. Ngo-1993 ngoMar-Apr; 21 (2): 74-80. Ukufundwa kwe-crossover ezimbini eziyimfama ezimbini ze-cyclobenzaprine regimens kwi-primary fibromyalgia syndrome.

USmith B, et al. Iikhompyutheni zeeDrug. IYunivesithi yezeMpilo neYunivesithi yaseOregon; Ngo-2011 kuMatshi Izidakamizwa ze-Fibromyalgia: I-Final Original Report.

Tofferi JK, Jackson JL, O'Malley PG. Arthritis kunye ne-rheumatism. 2004 Feb 15; 51 (1): 9-13. Unyango lwe-fibromyalgia nge-cyclobenzaprine: I-meta-analysis.